StockTipsArenaBeta

BUY Divi's Laboratories Limited — Chandan Taparia, Motilal Oswal

BUYDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

byChandan Taparia, Motilal OswalHorizon: NA (inferred Swing (≤2wk))13 Nov 2026via CNBC Awaaz.

Entry₹11,597Inferred
Target₹12,400
Total upside +6.92%
Stop loss₹11,200-3.42% risk
CMP₹11,4421d ago
Active-1.34%+8.37%upside left 12d left
Follow Chandan Taparia for new calls(36% target hit, 311 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 281 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:30 am IST
9 supporting1 neutral1 opposing
Supports the BUY call (9)

MACD above its signal line — bullish momentum

Technicals · macd·14 Nov · today

Past week's volume 1.7× the 30-day average

Technicals · volume·13 Nov · yesterday

Tata Steel, Divi's Labs In Focus After Q2 Results; HDFC Securities Sees Up To 34% Upside; Check New Target Prices

NewsNdtv-Profit·12 Nov · 2d ago

(opens in new tab)

Divi's Laboratories Market Cap Crosses Rs 3 Lakh Crore: What Is Driving The Rally

NewsNdtv-Profit·9 Nov · 5d ago

(opens in new tab)

Divi's Laboratories shares hit record high rising 84% YTD; buy, sell or hold after Q2 results 2026? Brokerages report

NewsLivemint·9 Nov · 5d ago

(opens in new tab)
Neutral / worth noting (1)

Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·7 Nov · 1w ago

(opens in new tab)
Weighs against the BUY call (1)

RSI at 91 — overbought territory

Technicals · rsi·14 Nov · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Chandan Taparia, Motilal Oswal

Every call and its outcome